FNY Investment Advisers’s Checkpoint Therapeutics CKPT Stock Holding History

FNY Investment Advisers’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,100	Closed	-$40K	–	993
2025 Q1	$40K	Buy	+10,100	New	+$33.7K	0.02%	312

FNY Investment Advisers's CKPT Position: Q2 2025 in Review

FNY Investment Advisers sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 10,100 shares — an estimated $40K sold.

FNY Investment Advisers first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $40K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

FNY Investment Advisers reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
FNY Investment Advisers sold 10,100 Checkpoint Therapeutics shares in Q2 2025, an estimated $40K.
FNY Investment Advisers first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
FNY Investment Advisers's Checkpoint Therapeutics position peaked at $40K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on FNY Investment Advisers's 13F filing for Q2 2025, filed 30 Jul 2025.